Opus Genetics, Inc.
🏢 View company profile →5Patents
5Active
5Granted
58Portfolio score
Filing activity: Oct 15, 2019 → Feb 28, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12312308B2 | Salts and esters of APX3330 and therapeutic uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12201616B2 | Methods and compositions for treatment of mydriasis | Human Necessities | 0 | Active |
| US12350366B2 | Aqueous ophthalmic solutions of phentolamine and medical uses thereof | Human Necessities | 0 | Active |
| US12201615B2 | Methods and compositions for treatment of mydriasis | Human Necessities | 0 | Active |
| US12161629B2 | Methods and compositions for treatment of glaucoma and related conditions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.